Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | LU | RZLV |
|---|---|---|
| Price | $0.93 | $1.92 |
| Change today | ▼ 5.67% | ▼ 7.93% |
| Market cap | $802.38M | $798.30M |
| Return, 3 months | -31.9% | -26.9% |
| Return, year to date | -63.8% | -25.5% |
| Return, 1 year | -76.8% | -69.3% |
| P/E (TTM) | -2.4 | -4.0 |
| P/B | 0.1 | 1.9 |
| P/E percentile vs own 5y | 47th | 29th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -15.7% | +2,224.2% |
| Net profit growth (YoY) | +86.3% | +41.5% |
| Gross margin | – | 51.8% |
| Operating margin | – | -106.6% |
| Net margin | -10.3% | -106.9% |
| Return on equity | -2.8% | -94.4% |
| Analyst target vs. price | +94.4% | +396.1% |
| Analyst buy share | 50% | 100% |
| RSI (14) | 31 | 39 |
| 30-day volatility | 74.4% | 68.5% |
| Max drawdown, 1 year | -77.7% | -69.7% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
